News Cannara Biotech Inc. Canadian Securities Exchange

Equities

LOVE

CA13765U1012

Delayed Canadian Securities Exchange Other stock markets			5-day change	1st Jan Change
- ^CAD	-.--%		-.--%	+87.50%

Jan. 29	Cannara Biotech Inc. Reports Earnings Results for the First Quarter Ended November 30, 2023	CI
2023	Cannara Biotech Inc. Reports Earnings Results for the Full Year Ended August 31, 2023	CI

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Cannara Biotech CFO Nicholas Sosiak: Unveiling Success Strategies and Future Plans	Feb. 08	AQ
Cannara Biotech Inc. Reports Earnings Results for the First Quarter Ended November 30, 2023	Jan. 29	CI
Cannara Biotech to Host Investor Webcast on Thursday December 14th, 2023	Dec. 11	AQ
Cannara Biotech Inc. Reports Earnings Results for the Full Year Ended August 31, 2023	Dec. 07	CI
Cannara Biotech's Fiscal Q4 Profit, Revenue Grows; Up 9.4%	Dec. 07	MT
Cannara Biotech Inc. Reports Earnings Results for the Fourth Quarter Ended August 31, 2023	Dec. 07	CI
Tranche Update on Cannara Biotech Inc.'s Equity Buyback Plan announced on November 30, 2022.	23-07-27	CI
Cannara Biotech Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended May 31, 2023	23-07-27	CI
Cannara Biotech Inc. Reports Record Q3 2023 Financial Results with Net Revenues of $15.9 Million and Net Income of $2.9 million	23-07-27	PR
Cannara Biotech Inc Announces Participation in the LD Micro Invitational XIII	23-05-23	NE
Tranche Update on Cannara Biotech Inc.'s Equity Buyback Plan announced on November 30, 2022.	23-04-24	CI
Cannara Biotech Inc. Reports Earnings Results for the Second Quarter and Six Months Ended February 28, 2023	23-04-24	CI
Cannara Biotech Down Near 8% As Enters into an Automatic Share Purchase Plan	23-02-28	MT
Cannara Biotech Inc. Enters into an Automatic Share Purchase Plan	23-02-28	PR
Cannara biotech inc. Announces results of annual shareholder meeting and conversion into equity of a $5m convertible debenture at $0.18 cent per common share	23-02-13	AQ
Cannara Biotech Converts CA$5 Million Debenture, Plus Interest, into Nearly 30 Million Shares for Olymbec Investments	23-02-10	MT
Tranche Update on Cannara Biotech Inc.'s Equity Buyback Plan announced on November 30, 2022.	23-01-23	CI
Cannara Biotech Inc. Reports Earnings Results for the First Quarter Ended November 30, 2022	23-01-23	CI
Cannara Announces Proposed Share Consolidation	23-01-12	AQ
Cannara Biotech Reports Normal Course Issuer Bid for Common Shares	22-11-30	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Cannara Biotech Inc. Canadian Securities Exchange

Equities

LOVE

CA13765U1012

Summary

Filters